Growth Metrics

Protalix BioTherapeutics (PLX) Profit After Tax Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 33.04%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 30.60%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -154.28%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.80%
7 Evaxion A 62.56 Bn 62.54 Bn - 16.53%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -3.84%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 47.10%
10 Protalix BioTherapeutics 164.49 Mn 153.70 Mn 29.62 Mn 98.74%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 98.74%
Dec 31, 2025 -13.75%
Sep 30, 2025 38.56%
Jun 30, 2025 26.63%
Mar 31, 2025 -16.55%
Dec 31, 2024 43.81%
Sep 30, 2024 40.45%
Jun 30, 2024 41.91%
Mar 31, 2024 7.79%
Dec 31, 2023 -175.92%
Sep 30, 2023 25.92%
Jun 30, 2023 87.75%
Mar 31, 2023 -60.55%
Dec 31, 2022 -145.81%
Sep 30, 2022 -0.07%
Jun 30, 2022 11.68%
Mar 31, 2022 31.98%
Dec 31, 2021 -7.05%
Sep 30, 2021 7.60%
Jun 30, 2021 -9.93%
Mar 31, 2021 6.80%
Dec 31, 2020 26.49%
Sep 30, 2020 26.43%
Jun 30, 2020 -124.45%
Mar 31, 2020 26.51%
Dec 31, 2019 28.45%
Sep 30, 2019 21.25%
Jun 30, 2019 10.64%
Mar 31, 2019 5.46%
Dec 31, 2018 24.08%
Sep 30, 2018 -11.69%
Jun 30, 2018 -11.03%
Mar 31, 2018 -3.59%
Mar 31, 2017 -100.44%
Dec 31, 2016 48.50%
Sep 30, 2016 -8.25%
Jun 30, 2016 -16.65%
Mar 31, 2016 -25.78%
Dec 31, 2015 -7.93%
Sep 30, 2015 11.33%
Jun 30, 2015 -38.23%
Mar 31, 2015 -3.33%
Mar 31, 2014 -13.29%
Dec 31, 2013 -27.87%
Sep 30, 2013 -32.44%
Jun 30, 2013 12.02%